propranolol has been researched along with bleomycetin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, T; Ge, CX; Li, KL; Liu, XJ; Qin, ZP; Tai, MZ | 1 |
| Guo, L; Li, J; Song, D; Sun, J; Wang, L; Wu, C; Zhang, Y | 1 |
2 other study(ies) available for propranolol and bleomycetin
| Article | Year |
|---|---|
[Subsequent therapy for infantile hemangiomas after discontinuation of oral propranolol].
Topics: Administration, Oral; Bleomycin; Child, Preschool; Face; Female; Hemangioma; Humans; Hyperplasia; Hypertrophy; Infant; Injections, Intralesional; Male; Postoperative Period; Propranolol; Retrospective Studies; Surgery, Plastic; Treatment Outcome; Vasodilator Agents | 2015 |
Transcatheter Arterial Sclerosing Embolization for the Treatment of Giant Propranolol-Resistant Infantile Hemangiomas in the Parotid Region.
Topics: Antineoplastic Agents; Bleomycin; Drug Resistance, Neoplasm; Embolization, Therapeutic; Ethiodized Oil; Female; Hemangioma; Humans; Infant; Male; Parotid Neoplasms; Polyvinyl Alcohol; Propranolol; Sclerosing Solutions; Sclerotherapy; Time Factors; Treatment Outcome; Tumor Burden | 2021 |